Inhaled Steroids: First Line Treatment of Adult Asthma
Corticosteroids are the most potent inhaled anti-inflammatory drugs for asthma treatment. This paper reviews the clinical evidence supporting the early use of inhaled steroids in asthma as a first line treatment. Inhaled steroids can probably alter the course of asthma, especially in mild asthmatics...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1995-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/1995/170230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567730344034304 |
|---|---|
| author | André Cartier |
| author_facet | André Cartier |
| author_sort | André Cartier |
| collection | DOAJ |
| description | Corticosteroids are the most potent inhaled anti-inflammatory drugs for asthma treatment. This paper reviews the clinical evidence supporting the early use of inhaled steroids in asthma as a first line treatment. Inhaled steroids can probably alter the course of asthma, especially in mild asthmatics. Once they have been shown to improve control of asthma and even if the need for beta2-agonists is virtually nil, their use should be continued at low doses (ie, equivalent to 400 to 500 μg of budesonide or beclomethasone) for at least one year before attempting to reduce the dosage. |
| format | Article |
| id | doaj-art-6867dd2c3d2044feaf9031d65fe02283 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 1995-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-6867dd2c3d2044feaf9031d65fe022832025-02-03T01:00:40ZengWileyCanadian Respiratory Journal1198-22411995-01-012Suppl A10A12A10.1155/1995/170230Inhaled Steroids: First Line Treatment of Adult AsthmaAndré Cartier0Chest Department, Sacré-Coeur Hospital, Montreal, Quebec, CanadaCorticosteroids are the most potent inhaled anti-inflammatory drugs for asthma treatment. This paper reviews the clinical evidence supporting the early use of inhaled steroids in asthma as a first line treatment. Inhaled steroids can probably alter the course of asthma, especially in mild asthmatics. Once they have been shown to improve control of asthma and even if the need for beta2-agonists is virtually nil, their use should be continued at low doses (ie, equivalent to 400 to 500 μg of budesonide or beclomethasone) for at least one year before attempting to reduce the dosage.http://dx.doi.org/10.1155/1995/170230 |
| spellingShingle | André Cartier Inhaled Steroids: First Line Treatment of Adult Asthma Canadian Respiratory Journal |
| title | Inhaled Steroids: First Line Treatment of Adult Asthma |
| title_full | Inhaled Steroids: First Line Treatment of Adult Asthma |
| title_fullStr | Inhaled Steroids: First Line Treatment of Adult Asthma |
| title_full_unstemmed | Inhaled Steroids: First Line Treatment of Adult Asthma |
| title_short | Inhaled Steroids: First Line Treatment of Adult Asthma |
| title_sort | inhaled steroids first line treatment of adult asthma |
| url | http://dx.doi.org/10.1155/1995/170230 |
| work_keys_str_mv | AT andrecartier inhaledsteroidsfirstlinetreatmentofadultasthma |